Sven Brandt
Greifswald, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 10, 2019
Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.
Journal: PloS one
Published: November 11, 2015
Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.
Journal: Thrombosis and haemostasis
Published: July 06, 2015
Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria.
Journal: Thrombosis and haemostasis
Published: January 21, 2015
Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4.
Journal: Blood
Published: August 24, 2014
Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
Journal: Thrombosis and haemostasis
Published: August 02, 2013
Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.
Journal: Blood
Published: January 18, 2013
Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026